Duke combines immunotherapy, tumor-roasting nanotech to vaccinate mice against cancer – Durham Herald Sun
Durham Herald Sun |
Duke combines immunotherapy, tumor-roasting nanotech to vaccinate mice against cancer
Durham Herald Sun By combining an FDA-approved cancer immunotherapy with an emerging tumor-roasting nanotechnology, Duke University researchers improved the efficacy of both therapies in a proof-of-concept study using mice. The potent combination also attacked … |
